Kays Financial Advisory’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-14,920
Closed -$1.34M 122
2019
Q1
$1.34M Buy
14,920
+879
+6% +$76.2K 0.26% 54
2018
Q4
$1.17M Sell
14,041
-12,697
-47% -$1.19M 0.27% 66
2018
Q3
$2.88M Sell
26,738
-762
-3% -$83.6K 0.61% 29
2018
Q2
$3.02M Buy
27,500
+702
+3% +$73.1K 0.66% 29
2018
Q1
$2.69M Buy
26,798
+176
+0.7% +$18K 0.61% 29
2017
Q4
$2.62M Buy
26,622
+550
+2% +$52.1K 0.77% 29
2017
Q3
$2.44M Buy
26,072
+142
+0.5% +$15.1K 0.78% 27
2017
Q2
$2.88M Sell
25,930
-55
-0.2% -$5.82K 0.97% 17
2017
Q1
$2.55M Buy
25,985
+2,178
+9% +$208K 0.91% 18
2016
Q4
$2.19M Buy
23,807
+1,714
+8% +$148K 0.85% 19
2016
Q3
$1.87M Buy
22,093
+2,036
+10% +$171K 0.8% 19
2016
Q2
$1.63M Buy
20,057
+3,133
+19% +$239K 0.73% 19
2016
Q1
$1.21M Buy
16,924
+881
+5% +$59.1K 0.6% 23
2015
Q4
$1.14M Buy
16,043
+1,739
+12% +$117K 0.59% 23
2015
Q3
$879K Buy
14,304
+3,019
+27% +$211K 0.5% 26
2015
Q2
$818K Buy
11,285
+788
+8% +$58.2K 0.47% 22
2015
Q1
$807K Buy
10,497
+3,305
+46% +$237K 0.48% 20
2014
Q4
$482K Buy
7,192
+1,800
+33% +$114K 0.33% 30
2014
Q3
$327K Buy
5,392
+801
+17% +$49.4K 0.24% 34
2014
Q2
$269K Buy
+4,591
New +$269K 0.19% 36

Other funds holding DGX

Kays Financial Advisory's DGX Position: Q2 2019 in Review

Kays Financial Advisory sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 14,920 shares — an estimated $1.34M sold.

Kays Financial Advisory first reported a position in DGX in Q2 2014 and held it in 20 quarters. The position peaked at $3.02M in Q2 2018. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Kays Financial Advisory reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Kays Financial Advisory sold 14,920 Quest Diagnostics shares in Q2 2019, an estimated $1.34M.
  • Kays Financial Advisory first reported a position in Quest Diagnostics in Q2 2014 and held it in 20 quarters.
  • Kays Financial Advisory's Quest Diagnostics position peaked at $3.02M in Q2 2018.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Kays Financial Advisory's 13F filing for Q2 2019, filed 24 Jul 2019.